ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q3 2017. The put-call ratio across all filers is 4.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,288,000 | +45.2% | 34,500 | +3.0% | 0.02% | +46.2% |
| Q1 2017 | $887,000 | +92.0% | 33,510 | +85.2% | 0.01% | +62.5% |
| Q4 2016 | $462,000 | -76.9% | 18,092 | -76.1% | 0.01% | -75.8% |
| Q1 2016 | $1,997,000 | +11.4% | 75,678 | +60.7% | 0.03% | +32.0% |
| Q1 2015 | $1,793,000 | -59.1% | 47,100 | -58.2% | 0.02% | -55.4% |
| Q4 2014 | $4,386,000 | +113.4% | 112,600 | +65.6% | 0.06% | +107.4% |
| Q3 2014 | $2,055,000 | +338.2% | 67,986 | +392.6% | 0.03% | +350.0% |
| Q2 2014 | $469,000 | – | 13,802 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |